At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 1,400 enrolled
Drug / intervention
Shared Decision Makingbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
ENhancing Outcomes Through Goal Assessment and Generating Engagement in Diabetes Mellitus (ENGAGE-DM): A 12-month Study of the Impact of Combined Shared-decision Making and Brief Negotiated Interviewing on Disease Control and Medication Adherence in Patients With Diabetes
In Brief
A Phase 4 clinical trial evaluating Shared Decision Making for Diabetes Mellitus Type 2. Completed, enrolled 1,400 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate whether a combination of pharmacist-delivered patient engagement techniques improves disease control and medication adherence among patients with poorly-controlled diabetes compared with usual care. These engagement techniques include shared decision-making and brief negotiated interviewing and are delivered telephonically.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus Type 2
CountriesUnited States
CollaboratorsBrigham Women's Health
Timeline
Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedSep 2016
Enrollment StartOct 2016
Primary CompletionDec 2017
TodayJul 2026
First PostedSep 21, 2016
Enrollment StartOct 20, 2016
Primary CompletionDec 20, 2017
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 9.8 years ago
Interventions
Shared Decision Makingbehavioral
This prospective study will include 700 beneficiaries of Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ).